Amundi’s Cellcom Israel CEL Stock Holding History
Bought
Maintained
Sold
Other funds holding CEL
Amundi's CEL Position: Q2 2018 in Review
Amundi sold out of Cellcom Israel (CEL) in Q2 2018, closing a stake of 3,365 shares — an estimated $24K sold.
Amundi first reported a position in CEL in Q4 2017 and held it in 2 quarters. The position peaked at $34K in Q4 2017. 38 funds tracked by Wall St. Rank hold CEL as of Q2 2018.
- Amundi reported no remaining Cellcom Israel position as of Q2 2018 after selling out during the quarter.
- Amundi sold 3,365 Cellcom Israel shares in Q2 2018, an estimated $24K.
- Amundi first reported a position in Cellcom Israel in Q4 2017 and held it in 2 quarters.
- Amundi's Cellcom Israel position peaked at $34K in Q4 2017.
- 38 funds tracked by Wall St. Rank held Cellcom Israel as of Q2 2018.
Based on Amundi's 13F filing for Q2 2018, filed 13 Aug 2018.